Washington, May 9
A Covid-19 vaccine designed to be taken orally not only protects against the disease, but also decreases the airborne spread of the SARS-CoV-2 virus to other close contacts, according to a study conducted in animals.
The research, published in the journal Science Translational Medicine, demonstrates the potential of the vaccine to work through the mucosal tissue to neutralise SARS-CoV-2, limiting infections and the spread of active virus in airborne particles. “Considering most of the world is under-immunised, the possibility that a jabbed person with a breakthrough infection can spread Covid to unimmunised,” said Stephanie N Langel from Duke University Medical Centre. — PTI
Shanghai again tightens curbs
Beijing: Authorities in Shanghai have again tightened anti-virus restrictions, just as the city was emerging from a month of strict lockdown due to a Covid-19 outbreak. AP
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Already a Member? Sign In Now